Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Locally Advanced NSCLC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT03452592
What this trial is testing

Efficacy and Safety of Alflutinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer Patients With T790M

Who this might be right for
Advanced NSCLC Patients With T790M
Allist Pharmaceuticals, Inc. 220
Early research (Phase 1)Study completedNCT02507375
What this trial is testing

Pertuzumab With Erlotinib in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-Small Cell Lung Cancer
Hoffmann-La Roche 17
Testing effectiveness (Phase 2)Looking for participantsNCT05468242
What this trial is testing

Study of Tislelizumab for Locally Advanced Non-Small Cell Lung Cancer Following Neoadjuvant Chemotherapy Plus Tislelizumab ± Bevacizumab and Definitive Concurrent Chemoradiation Therapy

Who this might be right for
Stage III Non-small Cell Lung Cancer
Sun Yat-sen University 116
Testing effectiveness (Phase 2)Study completedNCT00071188
What this trial is testing

ZD6474 Alone or in Combination With Paclitaxel and Carboplatin in Subjects With Previously Untreated Locally Advanced or Metastatic Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Genzyme, a Sanofi Company
Testing effectiveness (Phase 2)UnknownNCT06334757
What this trial is testing

Serplulimab Plus Bevacizumab and Chemotherapy for EGFR-mutant Metastatic NSCLC Patients After EGFR-TKI Treatment Failure

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Henan Cancer Hospital 46
Testing effectiveness (Phase 2)Looking for participantsNCT05168566
What this trial is testing

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Teligene US 99
Testing effectiveness (Phase 2)Study completedNCT00074022
What this trial is testing

GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors

Who this might be right for
Recurrent Non-small Cell Lung CancerRecurrent Prostate CancerStage III Prostate Cancer+5 more
National Cancer Institute (NCI) 48
Not applicableActive Not RecruitingNCT06487156
What this trial is testing

Evaluate First-line Ipilimumab + Nivolumab in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 404
Large-scale testing (Phase 3)Looking for participantsNCT07222566
What this trial is testing

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-Small Cell Lung CancerNon-Small Cell Lung CancerCarcinoma, Non-Small-Cell Lung+3 more
Pfizer 1,410
Post-approval studies (Phase 4)Study completedNCT03092986
What this trial is testing

Outcome of Cisplatin and Vinblastine Versus Paclitaxel and Carboplatin as Sequential Chemotherapy Followed by Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60
Testing effectiveness (Phase 2)UnknownNCT03502850
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 507
Early research (Phase 1)UnknownNCT01711697
What this trial is testing

An Alternative Radiation Fractionation Strategy for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Stage IIA Non-small Cell Lung CancerStage IIB Non-small Cell Lung CancerStage IIIA Non-small Cell Lung Cancer+1 more
Emory University 16
Testing effectiveness (Phase 2)Study completedNCT02094261
What this trial is testing

Phase II AZD9291 Open Label Study in NSCLC After Previous EGFR TKI Therapy in EGFR and T790M Mutation Positive Tumours

Who this might be right for
Non Small Cell Lung Cancer
AstraZeneca 210
Large-scale testing (Phase 3)Looking for participantsNCT07109531
What this trial is testing

ASKC202 Combined With Limertinib Versus Platinum-based Chemotherapy in Treatment of Locally Advanced or Metastatic NSCLC With MET Amplification/Overexpression After Failure of EGFR-TKI Therapy

Who this might be right for
Locally Advanced or Metastatic NSCLC
Jiangsu Aosaikang Pharmaceutical Co., Ltd. 286
Testing effectiveness (Phase 2)UnknownNCT06667622
What this trial is testing

Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy

Who this might be right for
Chemoradiotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Study completedNCT00019929
What this trial is testing

Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)WithdrawnNCT03419559
What this trial is testing

Study of Autologous Tumor Infiltrating Lymphocytes (LN-145) In Combo With Durvalumab in Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Iovance Biotherapeutics, Inc.
Not applicableUnknownNCT05641870
What this trial is testing

Molecular Profiling and Dynamic Changes of ctDNA in Unresectable Locally Advanced NSCLC

Who this might be right for
Lung CancerStage III Lung CancerUnresectable Lung Carcinoma
Parc de Salut Mar 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06336954
What this trial is testing

Adibelimab, Famitinib and Chemotherapy for Advanced NSCLC After PD-1 Inhibitor Failure

Who this might be right for
Non Small Cell Lung Cancer
Second Affiliated Hospital of Xi'an Jiaotong University 40
Testing effectiveness (Phase 2)UnknownNCT05414630
What this trial is testing

Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer Stage III
Anhui Provincial Cancer Hospital 30
Next Page